Department of Neurology, Chongqing Traditional Chinese Medicine Hospital, Chong Qing, China.
Laboratory Research Center, The First Affiliated Hospital of Chongqing Medical University, Chong Qing, China.
Pain Physician. 2018 Nov;21(6):E633-E642.
The blood-brain barrier (BBB) is an important anatomical structure of the central nervous system (CNS) that limits the penetration of a variety of substances from the blood into the parenchyma. Dysfunction of the BBB is involved in various CNS disorders, including stroke, inflammation, and pain. However, the evidence concerning its role in migraine is insufficient.
This study will investigate whether recurrent headache increases BBB permeability and vascular endothelial growth factor (VEGF) expression in a rat model.
This study used an experimental design.
The research took place in the Laboratory Research Center at The First Affiliated Hospital of Chongqing Medical University.
Eighty male Sprague-Dawley rats were randomly divided into 3 groups: inflammatory soup (IS), control (PBS), and treatment (IS+Sumatriptan) groups. Recurrent headache was induced by episodic IS stimulation: 20 µL of IS were pumped into the dura 3 times per week in rats. The control group was administered 20 µL of PBS. The rats in the treatment group were simultaneously treated with sumatriptan (300 ug/kg, intraperitoneal) at the same time that IS was applied to the dura. Mechanical nociceptive thresholds were examined by electronic von Frey filaments with rigid tips. BBB permeability changes were measured with Evans blue (EB). The expression of VEGF was measured by double labeling and Western blotting.
After 4 IS applications, the mechanical nociceptive thresholds significantly decreased. In addition, the mechanical hypersensitivity persisted for 4 hours after 9 applications. Only after 9 applications did the BBB permeability increase, as demonstrated by the EB tracer. The BBB disruption was accompanied by an elevation in VEGF expression. Sumatriptan treatment significantly reduced the mechanical hypersensitivity induced by IS stimulations and decreased the BBB disruption and VEGF expression.
Potential mechanisms that underlie the relationship between BBB and VEGF were not examined in this study.
The present study showed that repeated IS stimulations induced long-lasting allodynia, increased BBB permeability, and upregulated VEGF expression, all of which could be attenuated by early sumatriptan treatment.
Migraine, inflammatory soup, blood-brain barrier, vascular endothelial growth factor, sumatriptan.
血脑屏障(BBB)是中枢神经系统(CNS)的重要解剖结构,它限制了各种物质从血液进入实质的渗透。BBB 功能障碍与各种 CNS 疾病有关,包括中风、炎症和疼痛。然而,其在偏头痛中的作用证据不足。
本研究旨在探讨在大鼠模型中,反复发作的头痛是否会增加 BBB 通透性和血管内皮生长因子(VEGF)的表达。
本研究采用实验设计。
研究在重庆医科大学第一附属医院实验室研究中心进行。
将 80 只雄性 Sprague-Dawley 大鼠随机分为 3 组:炎症汤(IS)组、对照组(PBS)和治疗组(IS+舒马曲坦)。通过间歇性 IS 刺激诱导反复发作性头痛:每周向大鼠硬膜内注射 20 μL IS 3 次。对照组给予 20 μL PBS。治疗组大鼠同时在硬膜内注射 IS 时给予舒马曲坦(300ug/kg,腹腔内)。采用刚性尖端的电子 von Frey 纤维测量机械性痛觉阈值。通过 Evans 蓝(EB)测量 BBB 通透性变化。通过双标记和 Western 印迹测量 VEGF 的表达。
在 4 次 IS 应用后,机械性痛觉阈值明显降低。此外,在 9 次应用后,机械性超敏反应持续 4 小时。只有在 9 次应用后,EB 示踪剂才显示 BBB 通透性增加。BBB 破坏伴随着 VEGF 表达的升高。舒马曲坦治疗可显著减轻 IS 刺激引起的机械性超敏反应,降低 BBB 破坏和 VEGF 表达。
本研究未检测 BBB 和 VEGF 之间关系的潜在机制。
本研究表明,反复 IS 刺激可引起长期的痛觉过敏、增加 BBB 通透性和上调 VEGF 表达,早期舒马曲坦治疗可减轻这些变化。
偏头痛、炎症汤、血脑屏障、血管内皮生长因子、舒马曲坦。